NEW FILINGS Company: Kyverna Therapeutcs, Inc. Symbol: KYTX (Nasdaq) Description: They are a patient-centered, clinical-stage biopharmaceutical company focused on developing cell therapies for patients suffering from autoimmune...

Want to keep track of the largest startup funding deals in 2023 with our curated list of $100 million-plus venture deals to U.S.-based companies?...

Want to keep track of the largest startup funding deals in 2023 with our curated list of $100 million-plus venture deals to U.S.-based companies?...

A team of scientists led by KOO Sagang from the Seoul National University and Center for Nanoparticle Research within the Institue for Basic Science...

Bacteria may seem like a strange ally in the battle against cancer.But in a new study, genetically engineered bacteria were part of a tag-team...

Plus: the latest on the Inflation Reduction Act and biotech financings of note By Jeff Cranmer, Executive Editor October 3, 2023 12:44 AM UTC Biopharma...

Oberli, M. A. et al. Lipid nanoparticle assisted mRNA delivery for potent cancer immunotherapy. Nano Lett. 17, 1326–1335 (2017).Article  CAS  PubMed  Google Scholar ...

This article first appeared in The Checkup, MIT Technology Review's weekly biotech newsletter. To receive it in your inbox every Thursday, and read articles like...

ARTICLE | FinancePlus: FDA lifts hold on Fulcrum’s trial and more, panel to discuss Geron’s imetelstat By BioCentury Staff August 22, 2023 11:52 PM UTC Basel-based Mysthera...

Want to keep track of the largest startup funding deals in 2023 with our new curated list of $100 million-plus venture deals...

Abcuro, a Biotech Startup, Secures Top Position in the Week's 10 Largest Funding RoundsIn the fast-paced world of biotechnology, securing funding is crucial for...